SCHEMBL2693085

SCHEMBL2693085

N#Cc1ccc(-n2ccc3c(-c4cnc5ccccc5c4)ccnc32)cc1Br

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 17/20 0.36
BIRC5 O15392 1/20 0.35
PDGFRB P09619 2/20 0.35
PDGFRA P16234 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL950675 0.85 HSP90AA1 (0.49) HSP90AA1BIRC5PDGFRBPDGFRA
SCHEMBL2692049 0.82 HSP90AA1 (0.54) HSP90AA1
SCHEMBL2692865 0.81 HSP90AA1 (0.53) HSP90AA1
SCHEMBL2694324 0.80 HSP90AA1 (0.54) HSP90AA1
SCHEMBL2696177 0.80 HSP90AA1 (0.56) HSP90AA1
SCHEMBL2694298 0.80 HSP90AA1 (0.58) HSP90AA1
SCHEMBL2694302 0.80 HSP90AA1 (0.58) HSP90AA1
SCHEMBL2692517 0.79 HSP90AA1 (0.55) HSP90AA1
SCHEMBL2692251 0.79 HSP90AA1 (0.53) HSP90AA1
SCHEMBL422414 0.77 BIRC5 (0.41) BIRC5PDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9273045-B2 Azabicyclo compound and salt thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2016-03-01 US disclosed
EP-2452940-B1 AZABICYCLO COMPOUND AND SALT THEREOF TAIHO PHARMACEUTICAL CO LTD (JP) 2014-12-17 EP disclosed
US-20140303162-A1 AZABICYCLO COMPOUND AND SALT THEREOF TAIHO PHARMACEUTICAL CO., LTD. (JP) 2014-10-09 US disclosed
US-8779142-B2 Azabicyclo compound and salt thereof TAIHO PHARMACEUTICAL CO., LTD. (JP) 2014-07-15 US disclosed
CN-102471335-A Azanebicyclic compound or salt thereof TAIHO PHARMACEUTICAL CO LTD 2012-05-23 CN disclosed
EP-2452940-A1 AZABICYCLO COMPOUND AND SALT THEREOF Taiho Pharmaceutical Co., Ltd. (JP) 2012-05-16 EP disclosed
US-20120108589-A1 AZABICYCLO COMPOUND AND SALT THEREOF TAIHO PHARMACEUTICAL CO., LTD. (JP) 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140303162-A1 AZABICYCLO COMPOUND AND SALT THEREOF HSP90AB1, HSP90AB2P, HSP90AA1 HSP90AA1 3/4885BIRC5 1180/4885PDGFRB 1638/4885
US-20120108589-A1 AZABICYCLO COMPOUND AND SALT THEREOF HSP90AB1, HSP90AB2P, HSP90AA1 HSP90AA1 3/4885BIRC5 1180/4885PDGFRB 1638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.